Effect of supplementation in treatment of polycystic ovary syndrome

Phase 3

Conditions: Polycystic ovary syndrome.
Sclerocystic ovary syndrome Stein-Leventhal syndrome
E28.2

Registration Number: IRCT201408155623N25

Lead Sponsor: Arak University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 70

Inclusion Criteria

Women aged 18-40 years
Diagnosed with PCOS

Exclusion Criteria

Menopause
Consumed selenium supplements and metformin in the last 3 months
Diabetic
Hypothyroidism
Used tobacco
Taking a special diet or effective drugs on hormonal profile like oral conceptive (OCP) and ovulation induction agents.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Eliza.

Secondary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Insulin sensitivity. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Using QUICKI formula.;Triglycerides. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;Total cholesterol. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;VLDL. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;LDL-cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.